The Journal of Organic Chemistry
Note
was concentrated. The residue was dissolved in anhydrous ether (30
mL). Then, DBU (2.7 g, 18 mmol) in ether (3 mL) was added at 0 °C
under argon. The mixture was left at room temperature overnight,
filtered through anhydrous Celite, and concentrated. After Kugelrohr
distillation N-[(1,1-dimethylethyl)diphenylsilyl]benzaldimine (6a)
(3.52 g, 56% yield) was obtained as a pale yellow oil, which solidified
CH2Cl2 (0.5 mL) by acetyl chloride (19 μL, 0.26 mmol) and
anhydrous pyridine (22 μL, 0.26 mmol). After 1 h at 0 °C and 3 h at
room temperature, the mixture was diluted by CH2Cl2 (5 mL), washed
by 10% aqueous citric acid and by water, dried over Na2SO4, filtered,
concentrated, and purified.
N-(Benzylidene amino)morpholine (7a). From morpholine (45
μL, 0.51 mmol) and oxaziridine 1a (375 mg, 0.58 mmol) in CH2Cl2 (1
mL) at 45 °C for 30 h, the general procedure afforded hydrazone 7a as
an orange solid (51.1 mg, 56% yield) after chromatography over silica
gel (ether/n-pentane = 1:4): mp 91−92 °C (lit.11 mp 88−89 °C, lit.40
mp 90−91 °C); Rf (1:4 ether/ n-pentane) 0.13; 1H NMR (300 MHz,
CDCl3) δ 3.11 (t, 4H, J = 4.9 Hz), 3.83 (t, 4H, J = 4.9 Hz), 7.21−7.31
(m, 3H), 7.52−7.55 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 51.9
(CH2), 66.5 (CH2), 126.2 (CH), 128.4 (CH), 128.6 (CH), 135.9 (C),
136.3 (CH).
N-(4-Nitrobenzylideneamino)morpholine 7b. From morpho-
line (23 μL, 0.26 mmol) and oxaziridine 1b (107 mg, 0.27 mmol) in
CHCl3, the general procedure afforded hydrazone 7b as an orange
solid (55.3 mg, 89% yield) after chromatography over silica gel
(CH2Cl2/n-pentane = 2:3): mp 150−152 °C (lit.45 mp 149−151 °C);
Rf (2:3 CH2Cl2/n-pentane) 0.07; 1H NMR (300 MHz, CDCl3) δ 3.20
(t, 4H, J = 5.0 Hz), 3.83 (t, 4H, J = 5.0 Hz), 7.46 (s, 1H), 7.64 (d, 2H,
J = 9.0 Hz), 8.23 (d, 2H, J = 9.0 Hz); 13C NMR (75 MHz, CDCl3) δ
51.3 (CH2), 66.3 (CH2), 124.0 (CH), 126.2 (CH), 131.6 (CH) 142.4
(C) 147.0 (C). Anal. Calcd for C11H13N3O3: C, 56.16; H, 5.57; N,
17.86. Found: C, 56.10; H, 5.56; N, 17.62.
4-Nitrobenzaldehyde N-Methyl-N-phenylhydrazone (9a).
From N-methylaniline (27 μL, 0.25 mmol) and oxaziridine 1b (101
mg, 0.25 mmol) at 45 °C for 3 days, the general procedure afforded
hydrazone 9a as an orange solid (48.6 mg, 76% yield) after
crystallization in ether/n-pentane: mp 132−133 °C (lit.46 mp 133−
134 °C); 1H NMR (300 MHz, CDCl3) δ 3.50 (s, 3H), 7.03 (t, 1H, J =
6.7 Hz),7.35−7.43 (m, 4H), 7.48 (s, 1H), 7.80 (d, 2H, J = 8.9 Hz),
8.23 (d, 2H, J = 8.9 Hz); 13C NMR (75 MHz, CDCl3) δ 33.7 (CH3),
116.0 (CH), 122.0 (CH), 124.1 (CH), 126.0 (CH), 128.7 (CH),
129.2 (CH), 143.2 (C), 146.5 (C), 147.2 (C). Anal. Calcd for
C14H13N3O2, 0.25 H2O: C, 64.73; H, 5.24; N, 16.18. Found: C, 64.44;
H, 5.12; N, 16.17.
1
on standing: mp 52−56 °C; Eb = 135−140 °C (p = 0.1 mbar); H
NMR (300 MHz, CDCl3) δ 1.08 (s, 9H), 7.28−7.41 (m, 10H), 7.57−
7.61 (m, 3H), 7.78−7.82 (m, 2H), 8.78 (s, 1H); 13C NMR (75 MHz,
CDCl3) δ 18.9 (C), 27.3 (CH3), 127.6 (CH), 128.5 (CH), 128.7
(CH), 129.4 (CH), 131.5 (CH), 133.7 (C), 136.0 (CH), 138.9 (C),
171.3 (CH); HRMS (ESI) for C23H25NSiNa [M + Na]+ calcd
366.1654, found 366.1655.
N-[(1,1-Dimethylethyl)diphenylsilyl]-4-nitrobenzaldimine
(6b). Under argon and at 0 °C, a solution of tert-butylhypochlorite44
(2.72 g, 25.1 mmol) in anhydrous CHCl3 (4 mL) was added dropwise
to N-[(1,1-dimethylethyl)diphenylsilyl]-4-nitrobenzenemethanamine
(5b) (6.50 g, 16.6 mmol) in anhydrous CHCl3 (25 mL). After 3 h
at 0 °C, the mixture was concentrated. The residue was dissolved in
anhydrous ether (30 mL) and reacted at 0 °C with DBU (3.2 mL, 21.4
mmol) under argon. The mixture was left at room temperature
overnight, filtered, and concentrated. The resulting residue was
recrystallized under argon from anhydrous boiling cyclohexane to
afford N-[(1,1-dimethylethyl)diphenylsilyl]-4-nitrobenzaldimine (6b)
1
(5.11 g, 79% yield) as a yellow solid: mp 96−97 °C; H NMR (300
MHz, CDCl3) δ 1.10 (s, 9H), 7.30−7.38 (m, 6H), 7.55−7.58 (m, 4H),
7.94 (d, 2H, J = 8.8 Hz), 8.23 (d, 2H, J = 8.8 Hz), 8.81 (s, 1H); 13C
NMR (75 MHz, CDCl3) δ 18.9 (C), 27.3 (CH3), 123.9 (CH), 127.8
(CH), 129.3 (CH), 129.8 (CH), 132.8 (C), 136.0 (CH), 143.2 (C),
149.5 (C), 168.8 (CH); HRMS (EI) for C19H15N2O2Si [M − t-Bu]+
calcd 331.0903, found 331.0930.
N-[(1,1-Dimethylethyl)diphenylsilyl]-3(4-nitrophenyl)-
oxaziridine (1b). To a freshly prepared m-CPBA solution in CH2Cl2
(0.45 M, 27 mL, 12.1 mmol, dried over MgSO4 and then filtered)13
under argon were added at 0 °C KOH (2.16 g, 38.5 mmol) and a
solution of N-[(1,1-dimethylethyl)diphenylsilyl]-4-nitrobenzaldimine
(6b) (4.28 g, 11.02 mmol) in anhydrous CH2Cl2 (5 mL). The slurry
was stirred for 1.5 h at 0 °C and then filtered through Celite. After
concentration in vacuo, the residue was divided in four fractions.
Before chromatography, silica gel (25 g) in petroleum ether (50 mL)
was reacted with TMSCl (2.7 g) for 30 min. The solvent was removed
in vacuo, and the silanized silica was heated at 190 °C for 2 h under
vacuum (0.1 mbar). Each fraction was purified by flash chromatog-
raphy under nitrogen over silanized silica gel (25 g, anhydrous
CH2Cl2/n-pentane = 2:3). N-[(1,1-Dimethylethyl)diphenylsilyl]-3(4-
nitrophenyl)oxaziridine (1b) (2.92 g, 66% yield) was obtained as a
pale yellow solid: mp 79−80 °C; Rf (2:3 CH2Cl2/n-pentane) 0.40; 1H
NMR (300 MHz, CDCl3) δ 1.15 (s, 9H), 4.57 (s, 1H), 7.37−7.53 (m,
6H), 7.62−7.67 (m, 4H), 7.74 (d, 2H, J = 8.1 Hz), 8.23 (d, 2H, J = 8.1
Hz); 13C NMR (75 MHz, CDCl3) δ 19.4 (C), 27.5 (CH3), 74.4 (CH),
123.6 (CH), 127.8 and 128.0 (CH), 128.8 (CH), 129.9 and 130.2 (C),
130.4 and 130.5 (CH), 136.1 and 136.2 (CH), 143.3 (C), 149.0 (C);
HRMS (ESI) for C23H24N2O3SiNa [M + Na]+ calcd 427.1454, found
427.1456. Anal. Calcd for C23H24N2O3Si: C, 68.29; H, 5.98. Found: C,
68.50; H, 6.12.
(2S)-N-(4-Nitrobenzylideneamino)-2-methoxymethylpyrroli-
dine (9b). From 2(S)-(methoxymethyl)pyrrolidine (45 μL, 0.36
mmol) and oxaziridine 1b (158 mg, 0.39 mmol) in CH3CN, general
procedure afforded hydrazone 9b as an orange solid (42.73 mg, 45%
yield) after chromatography over basic alumina (CH2Cl2/n-pentane =
15:85): mp 78−79 °C; Rf (3:7 CH2Cl2/n-pentane) 0.17; [α]23
=
D
1
−231 (c = 0.6, CH2Cl2); H NMR (300 MHz, CDCl3) δ 1.91−2.13
(m, 4H), 3.16−3.23 (m, 1H), 3.41 (s, 3H), 3.41−3.43 (m, 1H), 3.48
(dd, J = 6.3 Hz, J = 9.3 Hz, 1H), 3.58 (dd, J = 3.6 Hz, J = 9.3 Hz, 1H),
3.75 (m, 1H), 7.09 (s, 1H), 7.61 (d, 2H, J = 8.9 Hz), 8.15 (d, 2H, J =
8.9 Hz); 13C NMR (75 MHz, CDCl3) δ 22.3 (CH2), 26.9 (CH2), 48.3
(CH2), 59.3 and 63.0 (CH or CH3), 74.3 (CH2), 124.1 (CH), 124.9
(CH), 127.4 (CH), 144.1 (C), 145.7 (C); HRMS (EI) for
C13H17N3O3 [M]+ calcd 263.1270, found 263.1253.
(1R-2S)-N-(4-Nitrobenzylideneamino)ephedrine (9c). From
(1R,2S)-ephedrine (57.8 mg, 0.35 mmol) and oxaziridine 1b (150
mg, 0.36 mmol) in CH3CN at rt overnight, the general procedure
afforded hydrazone 9c as a viscous oil after chromatography over basic
alumina (CH2Cl2/n-pentane = 1:1) (69.06 mg, 63% yield): Rf (1:1
CH2Cl2/n-pentane) 0.20; [α]23D = −165 (c = 0.5, CH2Cl2); 1H NMR
(300 MHz, CDCl3) δ 1.14 (d, 3H, J = 6.9 Hz, CH3), 2.86 (s, 3H), 3.51
(qd, 1H, J = 6.9 Hz, J = 3.7 Hz), 3.67 (brs, 1H), 5.08 (d, 1H, J = 3.7
Hz), 7.04 (s, 1H), 7.16−7.32 (m, 5H), 7.50 (d, 2H, J = 8.9 Hz), 8.09
(d, 2H, J = 8.9 Hz); 13C NMR (75 MHz, CDCl3) δ 11.8 (CH3), 37.6
(CH3), 68.2 (CH), 76.7 (CH), 124.2 (CH), 125.2 (CH), 126.2 (CH),
127.2 (CH), 127.5 (CH), 128.3 (CH), 141.7 (C),143.2 (C), 146.0
(C); HRMS (ESI) for C17H19N3O3Na [M + Na]+) calcd 336.1324,
found 336.1321.
N-[(1,1-Dimethylethyl)diphenylsilyl]-3-phenyloxaziridine
(1a). The same procedure as used for 1b afforded expected oxaziridine
1a (0.361 g, 82% yield) from N-[(1,1-dimethylethyl)diphenylsilyl]-
1
benzaldimine (6a) (0.419 g, 1.22 mmol): mp 74−77 °C; H NMR
(300 MHz, CDCl3) δ 1.28 (s, 9H), 4.67 (s, 1H), 7.40−7.55 (m, 11H),
7.72 (m, 2H), 7.80 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 19.4 (C),
27.5 (CH3), 75.9 (CH), 127.8 and 127.9 (CH), 128.4 (CH), 129.8
(CH), 130.1 and 130.2 (CH), 130.4 and 130.8 (C), 135.5 (CH), 136.0
(C), 136.2 and 136.3 (CH); HRMS (ESI) for C23H25NOSiNa [M +
Na]+ calcd 382.1603, found 382.1604.
General Procedure for Amination of Amines by Oxaziridine
1b. To a solution of oxaziridine 1b (101 mg, 0.25 mmol) in anhydrous
acetonitrile (0.5 mL) was added the amine (0.25 mmol). The mixture
was stirred overnight at room temperature and concentrated before
purification or acylation. The crude product was acylated at 0 °C in
4-Nitrobenzaldehyde N-Phenylhydrazone (9d). From aniline
(23 μL, 0.25 mmol) and oxaziridine 1b (104 mg, 0.26 mmol) in
CH3CN at 50 °C for 3 days, general procedure afforded hydrazone 9d
as a solid after crystallization in n-pentane/isopropyl oxide (17.8 mg,
10975
dx.doi.org/10.1021/jo302182t | J. Org. Chem. 2012, 77, 10972−10977